We are live on
!
Find out more
RPC
Rossmore Private Capital Portfolio holdings
AUM
$1.24B
1-Year Est. Return
28.92%
This Fund
S&P 500
This Quarter
Est. Return
+6%
1 Year Est. Return
+28.92%
3 Year Est. Return
+75.43%
5 Year Est. Return
+104.51%
10 Year Est. Return
–
AUM
$809M
AUM Growth
+$47.9M
(+6.3%)
Cap. Flow
+$8.1M
Cap. Flow
% of AUM
1%
Top 10 Holdings %
Top 10 Hldgs %
38.57%
Holding
235
New
5
Increased
56
Reduced
63
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.83M |
| 2 |
NVIDIA
NVDA
|
+$1.36M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$606K |
| 4 |
Energy Transfer Partners
ET
|
+$483K |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$405K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$254K |
| 2 |
Apple
AAPL
|
+$249K |
| 3 |
Microsoft
MSFT
|
+$202K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$166K |
| 5 |
Intel
INTC
|
+$141K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.66% |
| 2 | Energy | 12.49% |
| 3 | Healthcare | 11.54% |
| 4 | Financials | 9.74% |
| 5 | Industrials | 7.23% |
Similar funds
MP
GX
HCA
CCA
NHAS
FLII
IC
HTHT
Rossmore Private Capital's Q3 2024 Portfolio in Review
As of Q3 2024, Rossmore Private Capital held 235 positions worth $809M, up 6.3% from $761M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 2.6%. Rossmore Private Capital opened 5 new positions and exited 1, leaving the 235-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Energy and Healthcare.
- Rossmore Private Capital's largest Q3 2024 buy was Energy Transfer Partners: 30,000 shares worth $482K.
- Rossmore Private Capital added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $2.83M increase.
- Rossmore Private Capital's biggest Q3 2024 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $254K.
- Rossmore Private Capital fully exited Matinas BioPharma in Q3 2024, selling an estimated $2.77K.
- Rossmore Private Capital's ten largest holdings make up 39% of its $809M portfolio in Q3 2024.
- Rossmore Private Capital opened 5 new positions and closed 1 in Q3 2024.
- Rossmore Private Capital's portfolio value rose 6.3% quarter-over-quarter to $809M.
Based on Rossmore Private Capital's 13F filing for Q3 2024, filed 5 Nov 2024.